Rebamipide mofetil structure
|
Common Name | Rebamipide mofetil | ||
---|---|---|---|---|
CAS Number | 1527495-76-6 | Molecular Weight | 483.94 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 743.9±60.0 °C at 760 mmHg | |
Molecular Formula | C25H26ClN3O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 403.7±32.9 °C |
Use of Rebamipide mofetilRebamipide mofetil is an orally active prodrug of Rebamipide (OPC12759). Rebamipide is a mucoprotective agent. Rebamipide induces COX-2 expression, increases PGE2 levels, and enhances gastric mucosal defense in a COX-2-dependent manner[1]. |
Name | 2-(4-Morpholinyl)ethyl N-(4-chlorobenzoyl)-3-(2-hydroxy-4-quinolinyl)-D-alaninate |
---|---|
Synonym | More Synonyms |
Description | Rebamipide mofetil is an orally active prodrug of Rebamipide (OPC12759). Rebamipide is a mucoprotective agent. Rebamipide induces COX-2 expression, increases PGE2 levels, and enhances gastric mucosal defense in a COX-2-dependent manner[1]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 743.9±60.0 °C at 760 mmHg |
Molecular Formula | C25H26ClN3O5 |
Molecular Weight | 483.94 |
Flash Point | 403.7±32.9 °C |
Exact Mass | 483.156097 |
LogP | 3.06 |
Vapour Pressure | 0.0±2.6 mmHg at 25°C |
Index of Refraction | 1.630 |
2-(4-Morpholinyl)ethyl N-(4-chlorobenzoyl)-3-(2-hydroxy-4-quinolinyl)-D-alaninate |
4-Quinolinepropanoic acid, α-[(4-chlorobenzoyl)amino]-2-hydroxy-, 2-(4-morpholinyl)ethyl ester, (αR)- |